64Cu-SAR-BBN
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 64Cu-SAR-BBN, covering 2025-08-29 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: 64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) [Phase 2]